Novotech and CNS Deal Expands CRO Services

October 15, 2018

Applied Clinical Trials

Novotech, an Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mission in hopes to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.

Read the full release here.

Related Content: